Response to the study by Collins et al "Retrospective review of adverse events associated with oral hydroxychloroquine use in patients with cicatricial alopecia."

J Am Acad Dermatol. 2022 Dec;87(6):e223-e224. doi: 10.1016/j.jaad.2022.08.057. Epub 2022 Sep 6.

Authors

Elizabeth J Klein¹, Maria Karim², Kristen Lo Sicco¹, Jerry Shapiro³

Affiliations

¹ Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.
² Department of Dermatology, Hackensack Meridian School of Medicine, Nutley, New Jersey.
³ Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York. Electronic address: Jerry.shapiro@nyulangone.org.

PMID: 36075283
DOI: 10.1016/j.jaad.2022.08.057

No abstract available

Keywords: adverse events; cicatricial alopecia; drug toxicity; frontal fibrosing alopecia; hydroxychloroquine; lichen planopilaris.

Publication types

Letter
Comment

MeSH terms

Alopecia / complications
Alopecia / drug therapy
Cicatrix / complications
Humans
Hydroxychloroquine* / adverse effects
Lichen Planus* / complications
Retrospective Studies

Substances

Hydroxychloroquine